Michael Greenberg
About Michael Greenberg
Dr. Michael Greenberg is a distinguished entrepreneur and neurosurgeon, known for co-founding Fio Corporation and transforming ISG Technologies into Cedara Software, a leader in medical imaging software.
Chief Executive Officer of Fio Corporation
Dr. Michael Greenberg serves as the Chief Executive Officer at Fio Corporation, a company he co-founded alongside Shlomit Dekel. Fio Corporation specializes in developing cutting-edge technology solutions, and under Dr. Greenberg's leadership, the company continues to innovate and impact the tech industry.
Co-founder of ISG Technologies
Before founding Fio Corporation, Dr. Michael Greenberg played a pivotal role in building ISG Technologies into Cedara Software, a global leader in medical imaging software. His innovative work helped create technology used in one billion medical procedures, including MRI, CT, and ultrasound, among others. Dr. Greenberg also established significant joint ventures with industry giants like Carl Zeiss and Mitsui & Co.
World Technology Standards and Recognitions
Throughout his career, Dr. Michael Greenberg has set three world technology standards in 3D medical imaging, imaging middleware platforms, and image-guided surgery. His contributions have earned him the Canada Award for Business Excellence in Innovation and the Canada Export Award. He successfully led NASDAQ and Toronto Stock Exchange public offerings, achieving a tenfold increase in share price and securing the #1 performer spot on the Toronto Stock Exchange.
Medical and Neuroscience Background
Dr. Michael Greenberg holds a medical degree from the University of Pennsylvania and trained as a neurosurgery resident at the University of Toronto. In addition, he conducted neuroscience research as a US National Institutes of Health postdoctoral fellow. His extensive medical and research background has significantly informed his innovative contributions to the healthcare technology sector.
Guiding Start-Ups to Commercial Success
Dr. Michael Greenberg has provided guidance to various start-ups, helping them transition from the prototype stage to successful commercialization. His expertise spans several healthcare sectors, including orthopaedic surgical implant planning, cardiac imaging, peritoneal dialysis devices, and chemical separators for nuclear pharmaceuticals. His guidance has been vital in bringing innovative solutions to market.